Lataa...
Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
Current treatment of T cell mediated autoimmune diseases relies mostly on strategies of global immunosuppression, which, in the long term, is accompanied by adverse side effects such as a reduced ability to control infections or malignancies. Therefore, new approaches need to be developed that targe...
Tallennettuna:
| Julkaisussa: | J Vis Exp |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MyJove Corporation
2014
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710085/ https://ncbi.nlm.nih.gov/pubmed/25145915 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3791/51859 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|